KEY POINTS
- Investigators developed a mechanistic model simulating lymphocyte circulation between blood, bone marrow, lymph nodes, spleen and other lymph-rich tissues after lung SBRT. It was optimized in 64 retrospectively treated NSCLC patients and independently tested in 51 patients from a randomized phase II trial, including 26 standard-planning and 25 immune-sparing patients.
- Test patients received five-fraction SBRT, with absolute lymphocyte counts measured at treatment completion, four weeks and six months. Across 147 test measurements, mean absolute prediction error was 0.28 ± 0.23 ×10⁹ cells/L, corresponding to a mean absolute percentage difference of 17% ± 15%; 83% of predictions were within 0.5 ×10⁹ cells/L of observed values.
- Prediction was most accurate immediately after treatment: mean absolute error was 0.24 ×10⁹ cells/L at treatment completion, compared with 0.30 at four weeks and 0.31 at six months. Predictions were also more accurate in the standard arm than the immune-sparing arm (0.25 vs 0.31 ×10⁹ cells/L).
- Measured lymphocyte depletion correlated with irradiation of several blood- and immune-rich structures, including the heart/great vessels, thoracic vertebral marrow and contoured thoracic lymphatic regions. Notably, lung dosimetric parameters themselves were not significantly associated with post-treatment lymphocyte percentage, and model residuals were largely independent of the dosimetric variables it was designed to capture.
- The model estimated a median lymphocyte nadir of 1.18 ×10⁹ cells/L, corresponding to 62.7% of baseline. Each higher percentage point in predicted nadir was associated with better overall survival (HR 0.906, 95% CI 0.848–0.969; p=0.004) and event-free survival (HR 0.946, 95% CI 0.902–0.991; p=0.019). In contrast, the measured four-week lymphocyte count was not significantly associated with survival.
- Using the median 62.7% predicted nadir as a cutoff, patients above the median had significantly better overall survival (p=0.043); the event-free survival difference did not reach significance (p=0.088).
- Mechanistic ablation suggested that lymphatic irradiation could matter more than irradiation of circulating blood alone. In one illustrative patient, completely sparing the modeled lymph-node compartment increased predicted 30-day lymphocyte level to >90% of baseline versus 49% with the full treatment model. This remains a modeling experiment rather than evidence that nodal avoidance improves outcomes.
CLINICAL TAKEAWAY
The study supports the idea that radiation-induced lymphocyte depletion after lung SBRT may depend heavily on dose to lymph-rich tissues, not simply dose to circulating blood or lung. The model is mechanistically attractive and independently tested, but survival analyses were exploratory and the approach requires prospective validation before immune-sparing objectives are incorporated into routine SBRT planning.
SOURCE
International Journal of Radiation Oncology, Biology, Physics